» Articles » PMID: 22848513

Polymorphisms in the ERCC5 Gene and Risk of Esophageal Squamous Cell Carcinoma (ESCC) in Eastern Chinese Populations

Overview
Journal PLoS One
Date 2012 Aug 1
PMID 22848513
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Excision repair cross complementing group 5 (ERCC5 or XPG) plays an important role in regulating DNA excision repair; its functional single nucleotide polymorphisms (SNPs) may alter DNA repair capacity and thus contribute to cancer risk.

Methodology/principal Findings: In a hospital-based case-control study of 1115 esophageal squamous cell carcinoma (ESCC) cases and 1117 cancer-free controls, we genotyped three potentially functional SNPs of ERCC5 (SNPs, rs2296147T>C, rs2094258C>T and rs873601G>A) and estimated crude and adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for their associations with risk of ESCC using unconditional logistic regression models. We also calculated false-positive report probabilities (FPRPs) for significant findings. We found that compared with the TT genotype, ERCC5 rs2296147 C variant genotypes were associated with a significantly lower ESCC risk (CT: adjusted OR = 0.76, 95% CI = 0.63-0.93, CT/CC: adjusted OR = 0.80, 95% CI = 0.67-0.96); however, this risk was not observed for the other two SNPs (rs2094258C>T and rs873601 G>A), nor in further stratification and haplotype analysis.

Conclusions/significances: These findings suggested that ERCC5 polymorphisms may contribute to risk of ESCC in Eastern Chinese populations, but the effect was weak and needs further validation by larger population-based case-control studies.

Citing Articles

Exploring Hepatocellular Carcinoma Pathogenesis: The Influence of Genetic Polymorphisms.

Mollazadeh S, Saeedi N, Al-Asady A, Ghorbani E, Khazaei M, Ryzhikov M Curr Pharm Des. 2024; 31(6):432-442.

PMID: 39297458 DOI: 10.2174/0113816128327773240827062719.


Overview of Risk Factors for Esophageal Squamous Cell Carcinoma in China.

Conway E, Wu H, Tian L Cancers (Basel). 2023; 15(23).

PMID: 38067307 PMC: 10705141. DOI: 10.3390/cancers15235604.


Association of ERCC5 Genetic Polymorphisms With Cirrhosis and Liver Cancer.

Yang G, Yang Y, Ma X, Huang L, Li W, Song X Technol Cancer Res Treat. 2020; 19:1533033820943244.

PMID: 32812509 PMC: 7440721. DOI: 10.1177/1533033820943244.


MassARRAY analysis of twelve cancer related SNPs in esophageal squamous cell carcinoma in J&K, India.

Shah R, Sharma V, Bhat A, Singh H, Sharma I, Verma S BMC Cancer. 2020; 20(1):497.

PMID: 32487238 PMC: 7268327. DOI: 10.1186/s12885-020-06991-2.


RNAseq analysis of bronchial epithelial cells to identify COPD-associated genes and SNPs.

Yeo J, Morales D, Chen T, Crawford E, Zhang X, Blomquist T BMC Pulm Med. 2018; 18(1):42.

PMID: 29506519 PMC: 5838965. DOI: 10.1186/s12890-018-0603-y.


References
1.
Li C, Hu Z, Liu Z, Wang L, Strom S, Gershenwald J . Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis. Cancer Epidemiol Biomarkers Prev. 2006; 15(12):2526-32. DOI: 10.1158/1055-9965.EPI-06-0672. View

2.
Mohrenweiser H . Survey of polymorphic sequence variation in the immediate 5' region of human DNA repair genes. Mutat Res. 2006; 616(1-2):221-6. DOI: 10.1016/j.mrfmmm.2006.11.008. View

3.
Chang-Claude J, Becher H, Blettner M, Qiu S, Yang G, Wahrendorf J . Familial aggregation of oesophageal cancer in a high incidence area in China. Int J Epidemiol. 1998; 26(6):1159-65. DOI: 10.1093/ije/26.6.1159. View

4.
Shen J, Desai M, Agrawal M, Kennedy D, Senie R, Santella R . Polymorphisms in nucleotide excision repair genes and DNA repair capacity phenotype in sisters discordant for breast cancer. Cancer Epidemiol Biomarkers Prev. 2006; 15(9):1614-9. DOI: 10.1158/1055-9965.EPI-06-0218. View

5.
Hiyama T, Yoshihara M, Tanaka S, Chayama K . Genetic polymorphisms and esophageal cancer risk. Int J Cancer. 2007; 121(8):1643-58. DOI: 10.1002/ijc.23044. View